| |
| |
|
| Insider
Information: |
Ramsay David A |
| Relationship: |
Director |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,587,962 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,197,643 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,587,962 |
|
|
| Total
Value |
$26,197,643 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
0
|
|
Stock
price went up :
|
46
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.8
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
VP and Chief Financial... |
2015-02-06 |
364,320 |
|
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
2,223,642 |
2012-05-09 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Director |
2022-08-22 |
0 |
2020-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVRA |
Savara Inc |
Director |
– • – |
2022-11-17 |
4 |
B |
$1.27 |
$11,303 |
D/D |
8,900 |
1,885,042 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-11-18 |
4 |
B |
$1.34 |
$21,606 |
D/D |
16,100 |
1,901,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-11-21 |
4 |
B |
$1.42 |
$35,532 |
D/D |
25,005 |
1,926,147 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-16 |
4 |
B |
$1.50 |
$512 |
D/D |
341 |
1,946,593 |
2.31 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-19 |
4 |
B |
$1.49 |
$60,834 |
D/D |
40,719 |
1,987,312 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-20 |
4 |
B |
$1.50 |
$20,759 |
D/D |
13,830 |
2,001,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-20 |
4 |
B |
$1.48 |
$5,307 |
D/D |
3,586 |
2,004,728 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-22 |
4 |
B |
$1.48 |
$61,127 |
D/D |
41,414 |
2,046,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-23 |
4 |
B |
$1.44 |
$22,665 |
D/D |
15,707 |
2,061,849 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-28 |
4 |
B |
$1.50 |
$4,923 |
D/D |
3,293 |
2,065,142 |
2.31 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-29 |
4 |
B |
$1.54 |
$10,752 |
D/D |
7,000 |
2,072,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-30 |
4 |
B |
$1.55 |
$44,834 |
D/D |
29,000 |
2,101,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-05-24 |
4 |
B |
$2.56 |
$127,800 |
D/D |
50,000 |
2,151,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-05-25 |
4 |
B |
$2.57 |
$33,130 |
D/D |
12,876 |
2,164,018 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-05-26 |
4 |
B |
$2.63 |
$97,599 |
D/D |
37,124 |
2,201,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
2,223,642 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2005-05-27 |
4 |
B |
$1.98 |
$19,924 |
D/D |
10,000 |
386,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2005-08-23 |
4 |
B |
$1.68 |
$8,438 |
D/D |
5,000 |
391,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2005-08-24 |
4 |
B |
$1.70 |
$17,000 |
D/D |
10,000 |
401,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-05-14 |
4 |
AS |
$10.19 |
$101,900 |
D/D |
(10,000) |
391,410 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-06-14 |
4 |
AS |
$10.06 |
$101,043 |
D/D |
(10,000) |
381,410 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-07-16 |
4 |
AS |
$9.74 |
$98,895 |
D/D |
(10,000) |
371,410 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-07-26 |
4 |
OE |
$0.39 |
$11,700 |
D/D |
30,000 |
401,410 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2008-03-18 |
4 |
B |
$4.50 |
$45,565 |
D/D |
10,000 |
411,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFOOfficer |
• – – |
2005-01-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
256,410 |
|
- |
|
93 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
